Income Statement
TG THERAPEUTICS, INC.
TGTX
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
616.29 | 329.00 | 233.66 | 2.79 | 6.69 | 0.15 | 0.15 | 0.15 | - | - | - | - | - | - | - |
|
Cost of Revenue
|
100.71 | 38.49 | 14.13 | - | - | - | - | - | - | - | - | - | - | - | - |
|
Gross Profit
|
515.57 | 290.52 | 219.53 | 2.79 | 6.69 | 0.15 | 0.15 | 0.15 | - | - | - | - | - | - | - |
|
Operating Expenses
|
392.25 | 248.59 | 198.90 | 195.62 | 351.46 | 273.75 | 169.21 | 174.55 | 118.86 | 79.12 | 63.33 | 55.87 | 23.12 | 27.80 | 0.88 |
|
Research & Development
|
160.22 | 94.29 | 76.19 | 125.35 | 222.58 | 165.90 | 154.18 | 159.39 | 102.53 | 69.23 | 47.71 | 40.09 | 13.66 | 21.36 | 0.33 |
|
Selling, General & Administrative
|
232.03 | 154.30 | 122.71 | 70.01 | 128.09 | 107.85 | 15.03 | 15.16 | 16.33 | 9.89 | 15.63 | 15.79 | 6.66 | 5.34 | 0.55 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
123.32 | 41.93 | 20.63 | -192.84 | -344.77 | -273.59 | -169.06 | -174.40 | -118.86 | -79.12 | -63.33 | -55.87 | -23.12 | -27.80 | -0.88 |
|
Non-Operating Income
|
-15.93 | -16.34 | -7.57 | -5.50 | -3.33 | -5.79 | -3.82 | 0.92 | 0.24 | 0.72 | 0.23 | -0.06 | 2.49 | 1.04 | - |
|
Interest Income
|
- | - | - | - | - | - | - | 0.86 | 0.29 | 0.32 | 0.17 | 0.06 | - | - | - |
|
Interest Expense
|
- | - | 12.62 | 10.19 | 5.64 | 6.33 | 5.29 | - | - | - | 0.97 | 0.93 | 0.95 | 0.91 | 0.01 |
|
Other Non-Op Income / Expense
|
10.79 | 7.69 | 5.04 | - | - | - | - | - | - | - | - | - | - | - | - |
|
Income Before Tax
|
107.39 | 25.59 | 13.06 | -198.34 | -348.10 | -279.38 | -172.87 | -173.48 | -118.48 | -78.25 | -62.95 | -55.78 | -20.48 | -25.85 | - |
|
Income Tax Expense
|
-339.79 | 2.21 | 0.39 | - | - | - | - | - | - | - | - | - | 0.00 | -7.82 | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | - | - | - | - | 0.00 | -8.11 | -0.04 |
|
Net Income
|
447.18 | 23.38 | 12.67 | -198.34 | -348.10 | -279.38 | -172.87 | -173.48 | -118.48 | -78.25 | -62.95 | -55.78 | -20.48 | -18.93 | -0.85 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
123.38 | 42.00 | 20.84 | -192.84 | -344.77 | -273.59 | -169.06 | -174.40 | -118.86 | -79.12 | -63.33 | -55.87 | -23.12 | -27.80 | -0.88 |
|
Earnings Per Share (Basic)
|
3.10 | 0.16 | 0.09 | -1.46 | - | - | - | - | - | - | - | - | - | - | - |
|
Diluted EPS
|
2.77 | 0.15 | 0.09 | -1.46 | - | - | - | - | - | - | - | - | - | - | - |
|
Weighted Average Shares
|
144.32 | 145.32 | 141.96 | 135.41 | - | - | - | - | - | - | - | - | - | - | - |
|
Diluted Weighted Avg Shares
|
161.41 | 160.34 | 148.51 | 135.41 | - | - | - | - | - | - | - | - | - | - | - |
|
Comprehensive Income
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |